Lv4
640 积分 2023-07-11 加入
Metabolites as agents and targets for cancer immunotherapy
21小时前
待确认
From Concept to Cure: The Evolution of CAR-T Cell Therapy
3个月前
已完结
Outcomes of Relapsed or Refractory Diffuse Large B‐Cell Lymphoma Treated With R‐GemOx: A Multicenter Cohort Study
3个月前
已完结
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial
8个月前
已完结
Current understanding and management of CAR T cell-associated toxicities
8个月前
已完结
The present and future for CAR-T cell therapy in adult B-cell ALL
8个月前
已完结
The present and future for CAR-T cell therapy in adult B-cell ALL
8个月前
已关闭
Cancer immunotherapy by γδ T cells
8个月前
已完结
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma
9个月前
已完结
Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma
9个月前
已关闭
皖公网安备34019202002308
